Lv24
200 积分 2023-09-30 加入
Current status and influencing factors of the fear of disease progression in cancer patients
3小时前
已关闭
[Expert consensus on the diagnosis and treatment of anticancer drug-induced interstitial lung disease]
2天前
已完结
[Chinese expert consensus on the management of clinical pathway and adverse events of trastuzumab deruxtecan (2024 edition)]
3天前
已完结
Antibody-drug conjugates: A promising novel therapeutic approach in lung cancer
3天前
已完结
The effectiveness of e-Health interventions on caregiver burden, depression, and quality of life in informal caregivers of patients with cancer: A systematic review and meta-analysis of randomized controlled trials
5天前
已完结
Lorlatinib for advanced anaplastic lymphoma kinase–positive non–small cell lung cancer: Results of the IFCT-1803 LORLATU cohort
6天前
已完结
Real-world efficacy and safety of lorlatinib in treating advanced ALK-positive non–small cell lung cancer patients
6天前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
6天前
已完结
Antibody-drug conjugates: A promising novel therapeutic approach in lung cancer
7天前
已完结
Homogeneous multi-payload antibody–drug conjugates
7天前
已完结
皖公网安备34019202002308
